Literature DB >> 20163039

Anal transitional zone adenocarcinoma following restorative proctocolectomy for ulcerative colitis: case report and review of literature.

L Panier-Suffat1, M Marracino, A Resegotti, M Astegiano, A Giustetto, M Garino, R Pellicano, G Fronda.   

Abstract

Conservative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the intervention of choice for severe ulcerative colitis (UC) requiring surgery. Sporadically, the occurrence of carcinoma arising in or near the ileo-anal pouch after IPAA for UC has been reported. This issue is of utmost importance as an endoscopic follow-up is mandatory also after the operation. The present paper reports a case of cancer which developed four years after proctocolectomy with IPAA in a young man suffering from UC. Moreover, the authors provide update (PubMed research) by literature review on this issue.

Entities:  

Mesh:

Year:  2009        PMID: 20163039

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  3 in total

Review 1.  Long-term risk of adenocarcinoma post-ileal pouch-anal anastomosis for ulcerative colitis: report of two cases and review of the literature.

Authors:  James M O'Riordan; Richard Kirsch; Maryam Mohseni; Robin S McLeod; Zane Cohen
Journal:  Int J Colorectal Dis       Date:  2011-05-15       Impact factor: 2.571

2.  Adenocarcinoma below stapled ileoanal anastomosis after restorative proctocolectomy for ulcerative colitis.

Authors:  Luciano Alessandroni; Anna Kohn; Massimo Capaldi; Ilaria Guadagni; Andrea Scotti; Roberto Tersigni
Journal:  Updates Surg       Date:  2011-07-26

Review 3.  Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis.

Authors:  Guillaume Le Cosquer; Etienne Buscail; Cyrielle Gilletta; Céline Deraison; Jean-Pierre Duffas; Barbara Bournet; Géraud Tuyeras; Nathalie Vergnolle; Louis Buscail
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.